Virtu KCG Holdings’s Novavax NVAX Stock Holding History

Virtu KCG Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$48K	Sell	2,066 -6,874	-77%	-$135K	﹤0.01%	2600
2017 Q1	$229K	Buy	8,940 +5,515	+161%	+$152K	0.01%	2279
2016 Q4	$86K	Sell	3,425 -2,880	-46%	-$84K	﹤0.01%	2961
2016 Q3	$262K	Buy	6,305 +1,746	+38%	+$225K	0.01%	2081
2016 Q2	$663K	Buy	4,559 +1,053	+30%	+$121K	0.01%	1096
2016 Q1	$362K	Buy	3,506 +2,022	+136%	+$217K	0.01%	1510
2015 Q4	$249K	Sell	1,484 -14,711	-91%	-$2.26M	﹤0.01%	2400
2015 Q3	$2.29M	Buy	+16,195	New	+$3.63M	0.04%	379
2015 Q2	–	Sell	-1,054	Closed	-$174K	–	3622
2015 Q1	$174K	Buy	+1,054	New	+$171K	﹤0.01%	2464
2014 Q4	–	Sell	-7,578	Closed	-$632K	–	4084
2014 Q3	$632K	Buy	7,578 +6,405	+546%	+$579K	0.01%	1427
2014 Q2	$108K	Buy	+1,173	New	+$103K	﹤0.01%	3278
2014 Q1	–	Sell	-872	Closed	-$89K	–	3904
2013 Q4	$89K	Sell	872 -2,900	-77%	-$205K	﹤0.01%	3473
2013 Q3	$238K	Buy	+3,772	New	+$212K	﹤0.01%	2911

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu KCG Holdings's NVAX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Novavax (NVAX) stake by 77% in Q2 2017, selling an estimated $135K and leaving 2,066 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Virtu KCG Holdings first reported a position in NVAX in Q3 2013 and has held it in 13 quarters since. The position peaked at $2.29M in Q3 2015. 127 funds tracked by Wall St. Rank hold NVAX as of Q2 2017.

Virtu KCG Holdings held 2,066 shares of Novavax worth $48K as of Q2 2017.
Virtu KCG Holdings sold 6,874 Novavax shares in Q2 2017, an estimated $135K.
Novavax made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2600 holding.
Virtu KCG Holdings first reported a position in Novavax in Q3 2013 and has held it in 13 quarters since.
Virtu KCG Holdings's Novavax position peaked at $2.29M in Q3 2015.
127 funds tracked by Wall St. Rank held Novavax as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.